Vyteris, Inc.
Vyteris Announces Launch of Initiative to Pursue Joint Development Agreements in Pain Management
Published in Medical Letter on the CDC and FDA, August 24th, 2008
"Our first successful FDA approval for our active patch transdermal system was for topical delivery of lidocaine, and we are now examining other drugs in pain management for use in our system as the next step in our market development," said Haro Hartounian, Ph D., president of Vyteris, Inc. "We believe the unique properties of several pain...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Syracuse University
Syracuse University scientists discover how some bacteria may steal iron from their human hosts - Arrhythmia
Urologists Should Recognize the Cardiac Safety of Prescribed Medications, Article Concludes - Life Sciences
Researchers from American University discuss findings in life sciences - Regulatory Actions
Research on regulatory actions reported by scientists at University of Washington - Regulatory Actions
Findings in regulatory actions reported from Center for Devices and Radiological Health - Breast Cancer Screening
New breast cancer screening study findings have been published by I. Carelli and colleagues - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
